All terms in EFO
| Label | Id | Description |
|---|---|---|
| taxane | CHEBI_36064 | |
| thrombin activatable fibrinolysis inhibitor activation peptide measurement | EFO_0008582 | [Quantification of the amount of the activation peptide of thrombin activatable fibrinolysis inhibitor in a blood sample, typically as a marker of the extent of TAFI activation. Cleavage of the activation peptide from the intact peptide makes the active site accesible to substrates.] |
| hydroxyurea | CHEBI_44423 | [An urea that has formula CH4N2O2.] |
| obsolete_peroxisomal acyl-CoA oxidase deficiency | Orphanet_2971 | |
| obsolete_prune belly syndrome | Orphanet_2970 | |
| acute myocardial infarction | EFO_0008583 | [Necrosis of the myocardium, as a result of interruption of the blood supply to the area. It is characterized by a severe and rapid onset of symptoms that may include chest pain, often radiating to the left arm and left side of the neck, dyspnea, sweating, and palpitations. [ NCI ], Necrosis of the myocardium, as a result of interruption of the blood supply to the area. It is characterized by a severe and rapid onset of symptoms that may include chest pain, often radiating to the left arm and left side of the neck, dyspnea, sweating, and palpitations.] |
| Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction | EFO_0008584 | |
| ST Elevation Myocardial Infarction | EFO_0008585 | [A myocardial infarction that produces elevation in the ST segments of the ECG. [ NCI ]] |
| Non-ST Elevation Myocardial Infarction | EFO_0008586 | [An electrocardiographic finding of a myocardial infarction that does not produce elevations in the ST segment of the EKG. [ NCI ]] |
| obsolete_chronic intestinal pseudoobstruction | Orphanet_2978 | |
| Paramecium bursaria Chlorella virus 1 | NCBITaxon_10506 | |
| obsolete_pseudoleprechaunism syndrome, Patterson type | Orphanet_2976 | |
| 46,XX disorder of sex development - skeletal anomalies | Orphanet_2975 | |
| 1,7-Dimethylxanthine measurement | EFO_0021547 | [Quantification of the amount of 1,7-Dimethylxanthine in a sample.] |
| 1,4-dihydro-1-Methyl-4-oxo-3-pyridinecarboxamide measurement | EFO_0021546 | [Quantification of the amount of 1,4-dihydro-1-Methyl-4-oxo-3-pyridinecarboxamide measurement in a sample.] |
| 46,XX disorder of sex development - anorectal anomalies | Orphanet_2973 | |
| 2-Aminoethanesulfonic acid measurement | EFO_0021549 | [Quantification of the amount of 2-Aminoethanesulfonic acid in a sample.] |
| Non-eruption of teeth - maxillary hypoplasia - genu valgum | Orphanet_2972 | [ and deformed ears.] |
| 2-(dimethylamino) guanosine measurement | EFO_0021548 | [Quantification of the amount of 2-(dimethylamino) guanosine in a sample.] |
| Hypocalcemic vitamin D-resistant rickets | Orphanet_93160 | [Hypocalcemic vitamin D-resistant rickets (HVDRR) is a hereditary disorder of vitamin D action characterized by hypocalcemia, severe rickets and in many cases alopecia.] |